Skip to main content
. 2021 Aug 30;8:1592–1598. doi: 10.1016/j.toxrep.2021.08.005

Table 2.

Indication, Timing, and Outcome of High Lamotrigine and Levetiracetam Serum/Plasma Drug Levels.

Lamotrigine level Levetiracetam level
> 14 mg/L ≥ 80 mg/L
(n = 597) (n = 134)
n (%) n (%)
Indication for Ordering Specific Drug Level
Documented overdose (intentional or accidental) 34 (5.7 %) 3 (2.2 %)
Routine check (not related to pregnancy) 286 (47.9 %) 54 (40.3 %)
Routine check pregnancy or post-partum 10 (1.7 %) 0 (0.0 %)
Seizures 16 (2.7 %) 4 (3.0 %)
Possible symptoms of drug toxicity 200 (33.5 %) 58 (43.3 %)
Unknown 51 (8.5 %) 15 (11.2 %)



Timing of level
Peak 6 (1.0 %) 1 (0.7 %)
Trough 7 (1.2 %) 0 (0.0 %)
Other specific timing 6 (1.0 %) 1 (0.7 %)
Random/unknown 578 (96.8 %) 132 (98.5 %)



Changes in Drug Dosing
Decreased, temporarily held, or discontinued maintenance dose 172 (28.8 %) 22 (16.4 %)
Maintained maintenance dose 273 (45.7 %) 51 (38.1 %)
Increased maintenance dose 27 (4.5 %) 2 (1.5 %)
Unknown 125 (20.9 %) 59 (44.0 %)